DBFM
NVO

Dickmeyer Boyce Financial Management’s Novo Nordisk NVO Stock Holding History

Dickmeyer Boyce Financial Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$366K Sell
9,664
-1,807
-16% -$83.3K 0.19% 98
2026
Q2 		$550K Buy
11,471
+966
+9% +$41.5K 0.28% 81
2026
Q1 		$386K Buy
+10,505
New +$498K 0.23% 90

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM

Dickmeyer Boyce Financial Management's NVO Position: Q3 2026 in Review

Dickmeyer Boyce Financial Management reduced its Novo Nordisk (NVO) stake by 16% in Q3 2026, selling an estimated $83.3K and leaving 9,664 shares worth $366K. The position accounts for 0.19% of the portfolio, ranked #98.

Dickmeyer Boyce Financial Management first reported a position in NVO in Q1 2026 and has held it in 3 quarters since. The position peaked at $550K in Q2 2026. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Dickmeyer Boyce Financial Management held 9,664 shares of Novo Nordisk worth $366K as of Q3 2026.
  • Dickmeyer Boyce Financial Management sold 1,807 Novo Nordisk shares in Q3 2026, an estimated $83.3K.
  • Novo Nordisk made up 0.19% of Dickmeyer Boyce Financial Management's portfolio in Q3 2026, its #98 holding.
  • Dickmeyer Boyce Financial Management first reported a position in Novo Nordisk in Q1 2026 and has held it in 3 quarters since.
  • Dickmeyer Boyce Financial Management's Novo Nordisk position peaked at $550K in Q2 2026.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Dickmeyer Boyce Financial Management's 13F filing for Q3 2026, filed 8 Oct 2026.